It is reported that TIM is upregulated in patients with relapse of estrogen receptor (ER)α-positive breast cancer, who have been treated with tamoxifen, and that TIM is overexpressed in OH-Tam-resistant breast cancer cells [23]. The gene discussed is TIMELESS; the disease is breast cancer.